There are 2949 resources available
ESMO-MCBS: What is new and how are we expanding
Presenter: Nathan Cherny
Session: Challenges in the development and real-world use of the ESMO-MCBS
Resources:
Slides
Webcast
How can the ESMO-MCBS contribute to a higher QoL for patients?
Presenter: Andrew Bottomley
Session: Challenges in the development and real-world use of the ESMO-MCBS
Resources:
Slides
Webcast
Prioritising cancer systemic therapies using the ESMO-MCBS: The Israeli experience
Presenter: Raya Leibowitz-Amit
Session: Challenges in the development and real-world use of the ESMO-MCBS
Resources:
Slides
Webcast
Shortcomings in study design: Implementation that can skew the ESMO-MCBS results
Presenter: Bishal Gyawali
Session: Challenges in the development and real-world use of the ESMO-MCBS
Resources:
Slides
Webcast
Q&A and live discussion, all Speakers online Chairs to moderate Q&A
Presenter: E.G. Elisabeth de Vries
Session: Challenges in the development and real-world use of the ESMO-MCBS
Resources:
Webcast
CN34 - Management of immunotherapy toxicities: A new challenge
Presenter: Laura Bascuñana Sanchez
Session: EONS13: Immunotherapy and precision oncology: What do patients need?
Resources:
Abstract
Slides
Webcast
LBA12 - PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer
Presenter: Erica Mayer
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
161O - Randomized preoperative window of opportunity (WOO) study with the CDK4/6 inhibitor abemaciclib in early breast cancer (EBC) patients and differential gene expression pathway analyses with palbociclib
Presenter: Monica Arnedos
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
360O - Telomerase reverse transcriptase (TERT) promoter mutation and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation-mediated sensitivity to temozolomide in IDH-wildtype glioblastoma: Is there a link?
Presenter: Michael Weller
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
362O - Perifocal edema volume correlates with density of tumour-infiltrating cytotoxic T cells in newly diagnosed glioblastoma
Presenter: Maximilian Mair
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast